Sphingolipid imbalance and inflammatory effects induced by uremic toxins in heart and kidney cells are reversed by dihydroceramide desaturase 1 inhibition
Feby Savira, Ruth Magaye, Carmen V. Scullino, Bernard L. Flynn, Stuart M. Pitson, Dovile Anderson, Darren J. Creek, Hua Yue, Xin Xiong, Li Huang, Danny Liew, Christopher M. Reid, David M. Kaye, Andrew R. Kompa, Bing H. Wang
Topics & Concepts
SphingolipidCeramideKidneyChemistryInternal medicineEndocrinologyPharmacologyMedicineBiochemistryApoptosisSphingolipid Metabolism and SignalingErythrocyte Function and PathophysiologyPhagocytosis and Immune Regulation